Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$17.37 - $25.34 $786,357 - $1.15 Million
-45,271 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$23.67 - $36.85 $99,035 - $154,180
-4,184 Reduced 8.46%
45,271 $1.11 Million
Q4 2020

Feb 02, 2021

BUY
$20.32 - $39.8 $597,529 - $1.17 Million
29,406 Added 146.67%
49,455 $1.67 Million
Q3 2020

Nov 05, 2020

BUY
$19.5 - $31.26 $15,600 - $25,008
800 Added 4.16%
20,049 $501,000
Q2 2020

Aug 12, 2020

BUY
$25.68 - $38.12 $494,314 - $733,771
19,249 New
19,249 $649,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.